Yao Akihisa | Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy And Center Of The

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
Noninvasive Estimation of Aortic Blood Flow Velocty by Bioelectrical Impedance
Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
-0137-ACUTE AND CHRONIC EFFECTS OF CIGARETTE SMOKING ON CARDIAC AUTONOMIC FUNCTION ASSESSED BY HEART RATE SPECTRAL ANALYSIS
Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination

もっと見る

スポンサーリンク